These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8447534)

  • 1. Comparison of classic and quantitative prognostic factors in hormone receptor-positive and hormone receptor-negative female breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Am J Surg; 1993 Mar; 165(3):307-11. PubMed ID: 8447534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotic indexes as prognostic predictors in female breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    J Cancer Res Clin Oncol; 1992; 118(1):75-81. PubMed ID: 1729263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Anticancer Res; 1991; 11(5):1701-6. PubMed ID: 1768039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in axillary lymph node-negative (pN-) breast carcinomas.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Eur J Cancer; 1991; 27(12):1555-9. PubMed ID: 1782062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic scores combining clinical, histological and morphometric variables in assessment of the disease outcome in female breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Int J Cancer; 1991 Dec; 49(6):886-92. PubMed ID: 1959993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
    Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer.
    Eskelinen M; Lipponen P; Papinaho S; Aaltomaa S; Kosma VM; Klemi P; Syrjänen K
    Int J Cancer; 1992 Jun; 51(4):555-61. PubMed ID: 1601520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor size, nuclear morphometry, mitotic indices as prognostic factors in axillary-lymph-node-positive breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Eur Surg Res; 1992; 24(3):160-8. PubMed ID: 1499604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone receptors as prognostic factors in female breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Ann Med; 1991 Dec; 23(6):643-8. PubMed ID: 1777219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of morphometry to classic prognosticators in breast cancer.
    Baak JP; Van Dop H; Kurver PH; Hermans J
    Cancer; 1985 Jul; 56(2):374-82. PubMed ID: 4005802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of a morphometric prognostic index in female breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Oncology; 1993; 50(1):57-62. PubMed ID: 8421599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of nuclear morphometric variables as prognostic predictors in breast cancer.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Anticancer Res; 1991; 11(4):1663-9. PubMed ID: 1746922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
    Meyer JS; Province MA
    Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volume corrected mitotic index (M/V index), mitotic activity index (MAI), and histological grading in breast cancer.
    Lipponen PK; Collan Y; Eskelinen MJ
    Int Surg; 1991; 76(4):245-9. PubMed ID: 1663917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
    Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
    Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
    Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
    [No Abstract]   [Full Text] [Related]  

  • 18. Apoptosis in breast cancer as related to histopathological characteristics and prognosis.
    Lipponen P; Aaltomaa S; Kosma VM; Syrjänen K
    Eur J Cancer; 1994; 30A(14):2068-73. PubMed ID: 7857705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.
    Ba JL; Liu CG; Jin F
    Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
    Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
    Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.